1. Home
  2. NXTC vs OMCC Comparison

NXTC vs OMCC Comparison

Compare NXTC & OMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXTC
  • OMCC
  • Stock Information
  • Founded
  • NXTC 2015
  • OMCC 1985
  • Country
  • NXTC United States
  • OMCC United States
  • Employees
  • NXTC N/A
  • OMCC N/A
  • Industry
  • NXTC Biotechnology: Pharmaceutical Preparations
  • OMCC
  • Sector
  • NXTC Health Care
  • OMCC
  • Exchange
  • NXTC Nasdaq
  • OMCC NYSE
  • Market Cap
  • NXTC 40.3M
  • OMCC 43.4M
  • IPO Year
  • NXTC 2019
  • OMCC N/A
  • Fundamental
  • Price
  • NXTC $1.31
  • OMCC $5.90
  • Analyst Decision
  • NXTC Strong Buy
  • OMCC
  • Analyst Count
  • NXTC 2
  • OMCC 0
  • Target Price
  • NXTC $4.00
  • OMCC N/A
  • AVG Volume (30 Days)
  • NXTC 44.0K
  • OMCC 13.7K
  • Earning Date
  • NXTC 11-07-2024
  • OMCC 11-29-2024
  • Dividend Yield
  • NXTC N/A
  • OMCC N/A
  • EPS Growth
  • NXTC N/A
  • OMCC N/A
  • EPS
  • NXTC N/A
  • OMCC N/A
  • Revenue
  • NXTC N/A
  • OMCC $22,185,000.00
  • Revenue This Year
  • NXTC N/A
  • OMCC N/A
  • Revenue Next Year
  • NXTC N/A
  • OMCC N/A
  • P/E Ratio
  • NXTC N/A
  • OMCC N/A
  • Revenue Growth
  • NXTC N/A
  • OMCC N/A
  • 52 Week Low
  • NXTC $1.03
  • OMCC $5.29
  • 52 Week High
  • NXTC $2.57
  • OMCC $7.55
  • Technical
  • Relative Strength Index (RSI)
  • NXTC 45.61
  • OMCC N/A
  • Support Level
  • NXTC $1.30
  • OMCC N/A
  • Resistance Level
  • NXTC $1.60
  • OMCC N/A
  • Average True Range (ATR)
  • NXTC 0.08
  • OMCC 0.00
  • MACD
  • NXTC 0.00
  • OMCC 0.00
  • Stochastic Oscillator
  • NXTC 12.12
  • OMCC 0.00

About NXTC NextCure Inc.

NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.

About OMCC OLD MARKET CAPITAL CORPORATION

Old Market Capital Corp formerly Nicholas Financial Inc is a specialized consumer finance company. It is engaged in acquiring and servicing automobile finance installment contracts for purchases of used and new automobiles and light trucks. It also originates direct consumer loans and sells consumer-finance-related products. The majority of its revenue comes from Interest and fee income.

Share on Social Networks: